{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:45:56Z","timestamp":1791859556855,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s10482-026-02416-5","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:40:14Z","timestamp":1788316814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The role of natural products in treatment of non-tuberculous mycobacterial infections: a systematic review"],"prefix":"10.1007","volume":"119","author":[{"given":"Shuai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9565-1282","authenticated-orcid":false,"given":"Yan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2906-0973","authenticated-orcid":false,"given":"Eied Saber Alamain","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6348-0180","authenticated-orcid":false,"given":"Fatemeh","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4205-829X","authenticated-orcid":false,"given":"Mahlagha","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"2416_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100948","volume":"68","author":"M Abavisani","year":"2023","unstructured":"Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A (2023) CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resist Updat 68:100948","journal-title":"Drug Resist Updat"},{"key":"2416_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.165777","volume":"520","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Sajjadi SM, Ebadpour N, Kesharwani P, Karav S, Sahebkar A (2025) RNA-based antibacterial agents: mechanisms, functional insights, and challenges in therapeutic development. Chem Eng J 520:165777","journal-title":"Chem Eng J"},{"issue":"8","key":"2416_CR3","first-page":"2380","volume":"16","author":"Z Amreen","year":"2025","unstructured":"Amreen Z, Shriyansha, Singh M (2025) Evaluation of antimicrobial activity of different extracts of Datura stramonium against Mycobacterium kansasii. Int J Pharm Sci Res 16(8):2380\u20132387","journal-title":"Int J Pharm Sci Res"},{"key":"2416_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207696","author":"SJ Bae","year":"2018","unstructured":"Bae SJ, Choi JW, Park BJ, Lee J, Jo EK, Lee YH et al (2018) Protective effects of a traditional herbal extract from Stellaria dichotoma var. Lanceolata against Mycobacterium abscessus infections. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0207696","journal-title":"PLoS ONE"},{"issue":"9","key":"2416_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139251","volume":"10","author":"SB Cha","year":"2015","unstructured":"Cha SB, Jeon BY, Kim WS, Kim J-S, Kim HM, Kwon KW et al (2015) Experimental reactivation of pulmonary Mycobacterium avium complex infection in a modified cornell-like murine model. PLoS ONE 10(9):e0139251","journal-title":"PLoS ONE"},{"key":"2416_CR6","doi-asserted-by":"publisher","first-page":"1394220","DOI":"10.3389\/fmicb.2024","volume":"15","author":"L Conyers","year":"2024","unstructured":"Conyers L, Saunders B (2024) Treatment for non-tuberculous mycobacteria: challenges and prospects. Front Microbiol 15:1394220. https:\/\/doi.org\/10.3389\/fmicb.2024","journal-title":"Front Microbiol"},{"issue":"7","key":"2416_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/03601234.2012.669331","volume":"47","author":"P Crandall","year":"2012","unstructured":"Crandall P, Ricke S, O\u2019Bryan C, Parrish N (2012) In vitro effects of citrus oils against Mycobacterium tuberculosis and non-tuberculous Mycobacteria of clinical importance. J Environ Sci Health Part B-Pestic Food Contam Agric Wastes 47(7):736\u2013741","journal-title":"J Environ Sci Health Part B-Pestic Food Contam Agric Wastes"},{"key":"2416_CR8","first-page":"10943","volume-title":"Natural products: an era of discovery in organic chemistry","author":"JM Crawford","year":"2021","unstructured":"Crawford JM, Tang G-L, Herzon SB (2021) Natural products: an era of discovery in organic chemistry. ACS Publications, pp 10943\u201310945"},{"key":"2416_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104411","author":"Y Enomoto","year":"2014","unstructured":"Enomoto Y, Hagiwara E, Komatsu S, Nishihira R, Baba T, Kitamura H et al (2014) Pilot quasi-randomized controlled study of herbal medicine Hochuekkito as an adjunct to conventional treatment for progressed pulmonary Mycobacterium avium complex disease. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0104411","journal-title":"PLoS ONE"},{"key":"2416_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01613","volume":"9","author":"JO Falkinham III","year":"2018","unstructured":"Falkinham JO III (2018) Challenges of NTM drug development. Front Microbiol 9:1613","journal-title":"Front Microbiol"},{"issue":"Suppl 5","key":"2416_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0031-6989(88)80836-1","volume":"20","author":"G Gabbrielli","year":"1988","unstructured":"Gabbrielli G, Loggini F, Cioni PL, Giannaccini B, Mancuso E (1988) Activity of lavandino essential oil against non-tubercular opportunistic rapid grown mycobacteria. Pharmacol Res Commun 20(Suppl 5):37\u201340","journal-title":"Pharmacol Res Commun"},{"key":"2416_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.watres.2025.123188","volume":"275","author":"Y Gan","year":"2025","unstructured":"Gan Y, Kurisu F, Simazaki D, Yoshida M, Fukano H, Komine T et al (2025) Unveiling significant regrowth and potential risk of nontuberculous mycobacteria in hospital water supply system. Water Res 275:123188","journal-title":"Water Res"},{"issue":"2","key":"2416_CR13","first-page":"90","volume":"5","author":"M George","year":"2023","unstructured":"George M (2023) Cutaneous non-tuberculous mycobacterial infections: an update. J Skin Sex Transm Dis 5(2):90\u201397","journal-title":"J Skin Sex Transm Dis"},{"issue":"4","key":"2416_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.chest.2020.10.031","volume":"159","author":"DE Griffith","year":"2021","unstructured":"Griffith DE, Aksamit TR (2021) Managing Mycobacterium avium complex lung disease with a little help from my friend. Chest 159(4):1372\u20131381","journal-title":"Chest"},{"issue":"4","key":"2416_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F et al (2007) An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367\u2013416","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"2416_CR16","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF et al (2017) British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 72(Suppl 2):ii1\u2013ii64","journal-title":"Thorax"},{"key":"2416_CR17","unstructured":"Health Q. (2024) Notifiable conditions anual reporting. Queensland Government. Available at: https:\/\/www.health.qld.gov.au\/clinical-practice\/guidelines-procedures\/diseases-infection\/surveillance\/reports\/notifiable\/annual (Accessed Feb 27, 2024)"},{"key":"2416_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02029","volume":"9","author":"JR Honda","year":"2018","unstructured":"Honda JR, Virdi R, Chan ED (2018) Global environmental nontuberculous mycobacteria and their contemporaneous man-made and natural niches. Front Microbiol 9:2029","journal-title":"Front Microbiol"},{"key":"2416_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, de Vries RB, Leenaars M, Ritskes-Hoitinga M, Langendam MW (2014) SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol 14:43","journal-title":"BMC Med Res Methodol"},{"issue":"4","key":"2416_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41570-020-0176-1","volume":"4","author":"JJ Hug","year":"2020","unstructured":"Hug JJ, Krug D, M\u00fcller R (2020) Bacteria as genetically programmable producers of bioactive natural products. Nat Rev Chem 4(4):172\u2013193","journal-title":"Nat Rev Chem"},{"issue":"2","key":"2416_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40121-022-00750-5","volume":"12","author":"TM Johnson","year":"2023","unstructured":"Johnson TM, Byrd TF, Drummond WK, Childs-Kean LM, Mahoney MV, Pearson JC et al (2023) Contemporary pharmacotherapies for nontuberculosis mycobacterial infections: a narrative review. Infect Dis Ther 12(2):343\u2013365","journal-title":"Infect Dis Ther"},{"key":"2416_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-13-8","author":"E Karunasena","year":"2013","unstructured":"Karunasena E, Kurkure PC, Lackey RD, McMahon KW, Kiernan EP, Graham S et al (2013) Effects of the probiotic Lactobacillus animalis in murine Mycobacterium avium subspecies paratuberculosis infection. BMC Microbiol. https:\/\/doi.org\/10.1186\/1471-2180-13-8","journal-title":"BMC Microbiol"},{"issue":"4","key":"2416_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.4046\/trd.2024.0033","volume":"87","author":"HJ Kim","year":"2024","unstructured":"Kim HJ (2024) Nonpharmacological treatment for nontuberculous mycobacterial pulmonary disease. Tuberc Respir Dis 87(4):451\u2013457","journal-title":"Tuberc Respir Dis"},{"issue":"22","key":"2416_CR24","first-page":"3652","volume":"5","author":"T Lawal","year":"2011","unstructured":"Lawal T, Adeniyi B, Idowu O, Moody J (2011) In vitro activities of Eucalyptus camaldulensis Dehnh. and Eucalyptus torelliana F. Muell. against non-tuberculous mycobacteria species. Afr J Microbiol Res 5(22):3652\u20133657","journal-title":"Afr J Microbiol Res"},{"key":"2416_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050833","author":"C Molina-Torres","year":"2023","unstructured":"Molina-Torres C, Pedraza-Rodr\u00edguez C, Vera-Cabrera L, Ocampo-Candiani J, Rivas-Morales C, Viveros-Valdez E (2023) Antimycobacterial activity of Hedeoma drummondii against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics12050833","journal-title":"Antibiotics (Basel)"},{"key":"2416_CR26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","author":"M Page","year":"2020","unstructured":"Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"2416_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"M Page","year":"2021","unstructured":"Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"5","key":"2416_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1099\/jmm.0.000962","volume":"68","author":"D Peru\u010d","year":"2019","unstructured":"Peru\u010d D, Ti\u0107ac B, Abram M, Brozni\u0107 D, \u0160tifter S, Staver MM et al (2019) Synergistic potential of Juniperus communis and Helichrysum italicum essential oils against nontuberculous mycobacteria. J Med Microbiol 68(5):703\u2013710","journal-title":"J Med Microbiol"},{"issue":"3","key":"2416_CR29","first-page":"223","volume":"71","author":"D Peru\u010d","year":"2020","unstructured":"Peru\u010d D, Ti\u0107ac B, Brozni\u0107 D, Gobin I (2020) Juniper and immortelle essential oils synergistically inhibit adhesion of nontuberculous mycobacteria to Acanthamoeba castellanii. Arh Hig Rada Toksikol 71(3):223\u2013230","journal-title":"Arh Hig Rada Toksikol"},{"key":"2416_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pr12010111","author":"D Peru\u010d","year":"2024","unstructured":"Peru\u010d D, \u0160tifter-Vretenar S, Planini\u0107 A, Gobin I (2024) Combined application of Juniperus communis essential oil and amikacin, clarithromycin and rifampicin against Mycobacterium avium and Mycobacterium intracellulare. Processes. https:\/\/doi.org\/10.3390\/pr12010111","journal-title":"Processes"},{"issue":"2","key":"2416_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/pr9020362","volume":"9","author":"D Peruc","year":"2021","unstructured":"Peruc D, Broznic D, Maglica Z, Marijanovic Z, Karleusa L, Gobin I (2021) Biofilm degradation of nontuberculous mycobacteria formed on stainless steel following treatment with immortelle (Helichrysum italicum) and common juniper (Juniperus communis) essential oils. Processes 9(2):362","journal-title":"Processes"},{"issue":"1","key":"2416_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/09603123.2020.1741519","volume":"32","author":"D Peruc","year":"2022","unstructured":"Peruc D, Ticac B, Broznic D, Maglica \u00c4, Sarolic M, Gobin I (2022) Juniperus communis essential oil limit the biofilm formation of Mycobacterium avium and Mycobacterium intracellulare on polystyrene in a temperature-dependent manner. Int J Environ Health Res 32(1):141\u2013154","journal-title":"Int J Environ Health Res"},{"issue":"1","key":"2416_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/ijmy.ijmy_228_20","volume":"10","author":"T Polyudova","year":"2021","unstructured":"Polyudova T, Eroshenko D, Pimenova E (2021) The biofilm formation of nontuberculous mycobacteria and its inhibition by essential oils. Int J Mycobacteriol 10(1):43\u201350","journal-title":"Int J Mycobacteriol"},{"key":"2416_CR34","doi-asserted-by":"crossref","unstructured":"Porvaznik I, Solovi\u010d I, Mokr\u00fd J. (2016) Non-tuberculous mycobacteria: classification, diagnostics, and therapy. Respir Treat Prev 19\u201325","DOI":"10.1007\/5584_2016_45"},{"issue":"3","key":"2416_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.24425\/pjvs.2024.151738","volume":"27","author":"K Puk","year":"2024","unstructured":"Puk K, Guz L, Pastuszka A (2024) Berberine enhances the antibacterial activity of thymoquinone, carvacrol and thymol against multi-drug resistant nontuberculous mycobacteria. Pol J Vet Sci 27(3):469\u2013473","journal-title":"Pol J Vet Sci"},{"key":"2416_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00303","volume":"11","author":"CN Ratnatunga","year":"2020","unstructured":"Ratnatunga CN, Lutzky VP, Kupz A, Doolan DL, Reid DW, Field M et al (2020) The rise of non-tuberculosis mycobacterial lung disease. Front Immunol 11:303","journal-title":"Front Immunol"},{"issue":"2","key":"2416_CR37","volume":"10","author":"S Saxena","year":"2021","unstructured":"Saxena S, Spaink HP, Forn-Cun\u00ed G (2021) Drug resistance in nontuberculous mycobacteria: mechanisms and models. Biology (Basel) 10(2):96","journal-title":"Biology (Basel)"},{"issue":"2","key":"2416_CR38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.toxlet.2009.05.013","volume":"189","author":"K Schneider","year":"2009","unstructured":"Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A et al (2009) ToxRTool\", a new tool to assess the reliability of toxicological data. Toxicol Lett 189(2):138\u2013144","journal-title":"Toxicol Lett"},{"key":"2416_CR39","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_902_20","author":"SK Sharma","year":"2020","unstructured":"Sharma SK, Upadhyay V (2020) Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. https:\/\/doi.org\/10.4103\/ijmr.IJMR_902_20","journal-title":"Indian J Med Res"},{"issue":"1","key":"2416_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0924-8579(98)00078-8","volume":"11","author":"T Shimizu","year":"1999","unstructured":"Shimizu T, Tomioka H, Sato K, Sano C, Yamada Y, Shibata H et al (1999) Effects of Yokuinin on the therapeutic efficacy of a new benzoxazinorifamycin KRM-1648 against Mycobacterium avium infection. Int J Antimicrob Agents 11(1):69\u201374","journal-title":"Int J Antimicrob Agents"},{"key":"2416_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010038","author":"S Sideek","year":"2023","unstructured":"Sideek S, El-Nassan H, Fares A (2023) Different curcumin-loaded delivery systems for wound healing applications: a comprehensive review. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15010038","journal-title":"Pharmaceutics"},{"issue":"11","key":"2416_CR42","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3390\/ph15111367","volume":"15","author":"V Srivastava","year":"2022","unstructured":"Srivastava V, Navabharath M, Gupta S, Singh SV, Ahmad S (2022) Exploration of Solanum xanthocarpum Schrad. & Wendl. against Mycobacterium avium Subspecies paratuberculosis and assessment of its immunomodulatory and anti-inflammatory potential. Pharmaceuticals 15(11):1367","journal-title":"Pharmaceuticals"},{"key":"2416_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"issue":"6","key":"2416_CR44","doi-asserted-by":"publisher","first-page":"e02672","DOI":"10.1128\/spectrum.02672-22","volume":"10","author":"J Sullivan","year":"2022","unstructured":"Sullivan J, Yao J, Courtine C, Lupien A, Herrmann J, M\u00fcller R et al (2022) Natural products Lysobactin and Sorangicin A show in vitro activity against Mycobacterium abscessus complex. Microbiol Spectr 10(6):e02672","journal-title":"Microbiol Spectr"},{"key":"2416_CR45","doi-asserted-by":"publisher","first-page":"1686049","DOI":"10.3389\/fntpr.2025","volume":"4","author":"N Teli","year":"2025","unstructured":"Teli N, Upadhyay K (2025) Bridging Eras: integrating ancient remedies with modern biotechnology to combat Non-TB skin infections. Front Nat Prod 4:1686049. https:\/\/doi.org\/10.3389\/fntpr.2025","journal-title":"Front Nat Prod"},{"issue":"3","key":"2416_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1513\/AnnalsATS.201612-994OI","volume":"14","author":"R Thomson","year":"2017","unstructured":"Thomson R, Donnan E, Konstantinos A (2017) Notification of nontuberculous mycobacteria: an Australian perspective. Ann Am Thorac Soc 14(3):318\u2013323","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"2416_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.4103\/ijmy.ijmy_211_23","volume":"13","author":"MM Vahabi","year":"2024","unstructured":"Vahabi MM, Bostanc\u0131 A, Ta\u015fbakan SE, Karaarslan I, \u00c7avu\u015fo\u011flu C, Ta\u015fbakan M (2024) Tuberculosis or nontuberculosis? A case of mycobacterial skin infection. Int J Mycobacteriol 13(3):351\u2013353","journal-title":"Int J Mycobacteriol"},{"issue":"19","key":"2416_CR48","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1128\/AEM.00981-08","volume":"74","author":"SYY Wong","year":"2008","unstructured":"Wong SYY, Grant IR, Friedman M, Elliott CT, Situ C (2008) Antibacterial activities of naturally occurring compounds against Mycobacterium avium subsp. paratuberculosis. Appl Environ Microbiol 74(19):5986\u20135990","journal-title":"Appl Environ Microbiol"},{"key":"2416_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.978120","volume":"9","author":"M Zhang","year":"2022","unstructured":"Zhang M, Chen X, Zhang Y, Zhao X, Zhao J, Wang X (2022) The potential of functionalized dressing releasing flavonoids facilitates scar-free healing. Front Med 9:978120","journal-title":"Front Med"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02416-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-026-02416-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02416-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:03:41Z","timestamp":1791857021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-026-02416-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2416"],"URL":"https:\/\/doi.org\/10.1007\/s10482-026-02416-5","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"212"}}